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article under the CC BY-NC-ND license (Abstract Background/purpose: Matrix metalloproteinases (MMPs) and tissue inhibitor of
MMPs (TIMPs) have been shown to play an important role in the pathogenesis of tissue destruc-
tion in periodontitis. The associations between single nucleotide polymorphisms (SNPs) in the
promoter regions of MMP-2, MMP-9, and TIMP-2 genes and the risk of aggressive periodontitis
(AgP) and chronic periodontitis (CP) were investigated in a Taiwanese population.
Materials and methods: MMP-2 C-1306T, C-735T, T-790G, and MMP-9 C-1562T and TIMP-2 G-
418C SNPs were genotyped by polymerase chain reaction-restriction fragment length polymor-
phism analysis in 69 patients and 129 patients with AgP and CP, respectively, and 117 peri-
odontal healthy individuals who served as healthy controls (HC). Chi-square test and logistic
regression analysis were used to investigate the possible association of genotypes with peri-
odontitis.
Results: No significant differences in the distributions of the C-1306T and C-735T variants be-
tween periodontitis and HC were detected. Patients with genotype of MMP-2 -790 TT or T allele
of MMP-2-790T/G as compared to genotypes of GT þ GG genotypes or G allele, were less sus-
ceptible to CP [odds ratio (OR) Z 0.50, 95% confidence interval (CI) Z 0.25e1.00 and
OR Z 0.52, 95% CI Z 0.28e0.96, respectively]. The frequencies of TIMP-2 G-418C gene poly-
morphisms in nonsmokers were statistically significantly different among AgP, CP, and HC
groups (P Z 0.024). The nonalcohol drinking participants with C allele of MMP-9 C-1562T as




n for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. This is an open access
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412 Y.-F. Hsiao et alConclusion: It is suggested that MMP-2 T-790G, MMP-9 C-1562T, and TIMP-2 G-418C gene poly-
morphisms might be associated with periodontitis in the Taiwanese Han population.
Copyright ª 2016, Association for Dental Sciences of the Republic of China. Published by Else-
vier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Periodontitis is a multifactorial disease that involves mi-
crobial challenge and host responses. Although bacteria are
the initial factors for human periodontitis, their impact
may be modified by an individual’s predisposition, which
can determine the manifestation and progression of the
disease.1 Matrix metalloproteinases (MMPs) play an impor-
tant role in physiological and pathological events, including
the repair and breakdown of connective tissue because of
the inflammatory response.2 Excessive production of MMPs
because of genetic polymorphisms may influence the
manifestation and development of periodontal diseases.3
MMP-2 can broadly break down both type IV collagen and
noncollagenous components of extracellular matrix, and
also native type collagen type I collagen in the gingival
connective tissue matrix.4,5 MMP-2 has effects on stimu-
lating cell proliferation and inhibiting apoptosis. MMP-2 also
affects fibroblast growth factor-1, leading to the release of
the active soluble ectodomain of the receptor6; therefore,
it has the potential to modulate the mitogenic and angio-
genic activities of the fibroblast growth factor. These
findings suggest that MMP-2 can contribute not only to tis-
sue destruction but also to tissue repair. Elevated levels of
MMP-2 have been reported in gingival crevicular fluid and
gingival tissue of periodontitis.7,8
The constitutive and induced expression of MMP-2 is
likely to be subjected to regulation by transcription fac-
tors.9,10 Several single nucleotide polymorphisms (SNPs) in
the MMP-2 promoter region have been identified including
MMP-2 -1306 C>T (rs243865), MMP-2 -735C>T (rs2285053),
and MMP-2 -790T>G (rs243864).11e14 A C to T transition
located at nucleotides 1306 and a C to T allelic variation
located at 735 might disrupt a SP1-binding site and
consequently diminish promoter activity.11,14 The MMP-2
-790GG genotype was observed to be marginally less
frequent in patients with chronic periodontitis (CP).15
A large number of molecular epidemiological studies
have been performed to evaluate the role of these MMP-2
gene polymorphisms in various tumors.14,16e19 Considering
the role of MMP-2 in both remodeling and destruction of
extracellular matrix, we hypothesize that MMP-2 genetic
variations influencing the transcription or function of this
enzyme might contribute to the susceptibility to
periodontitis.
MMP-9 (gelatinase-B, 96 kDa gelatinase) is one of the
MMPs responsible for the breakdown of type IV collagen and
noncollagenous components of the extracellular matrix.4 In
addition, MMP-2dbut not MMP-9dis also able to cleave
native type I collagen, which is the abundant component of
gingival connective tissue matrix.5 Elevated levels of MMP-9
have been detected in gingival crevicular fluid and gingival
tissue of periodontitis patients.2,8 A single-base substitution
variant in the MMP-9 gene is located at the promoter site atposition 1562 relative to the transcription start site where
a transition between C and T occurs. The functional poly-
morphism is characterized with increased mRNA, protein
level, and activity in MMP-9 -1562 T allele carriers of MMP-
9.15
Tissue inhibitor of metalloproteinase-2 (TIMP-2) is
particularly important because of its dual functions in
terms of regulating MMP-2 activity.20e22 It is reasonable to
postulate that the polymorphism may downregulate TIMP-2
expression and consequently cause an imbalance between
the activities of TIMP-2 and MMP-2, which are believed to
have a significant impact on periodontitis development and
progression.23,24
Although some reports revealed that the polymorphisms
of MMP-2 (-1306 C/T, -735 C/T, and -790 T/G) and TIMP-2
-418 G/C were related to the risk of some diseases, so far
reports on the correlation between these polymorphisms
and the risk of periodontitis development/susceptibility
were rare and showed different results.1,15,25e27
Considering the role of MMP-2, MMP-9, and TIMP-2 in
both remodeling and destruction of the extracellular ma-
trix, whether genetic variations influencing the transcrip-
tion or function of these enzymes contribute to the
susceptibility to CP and aggressive periodontitis (AgP), we
aimed to evaluate the genotype distributions and allele
frequencies of MMP-2 -1306C/T, MMP-2 -735C/T, MMP-2
-790T/G, MMP-9 -1562C/T, and TIMP-2 -418G/C genes and
their relation to the susceptibility to severe periodontitis in
a Taiwanese Han population.Materials and methods
Study population
A total of unrelated Taiwanese individuals including 129 CP
and 69 AgP patients and 117 participants with healthy
periodontal condition were recruited from the Department
of Periodontology, Kaohsiung Medical University Hospital,
Kaohsiung City, Taiwan and Chung Shan Medical University
Hospital, Taichung City, Taiwan, between May 2006 and
July 2012. All participants underwent clinical and radio-
graphic examination. Medical and dental histories were
taken. Current smokers or former smokers who were
smoking > 10 cigarettes per day for > 5 years were tagged
as the smoking group. Participants who had never smoked
were classified as the nonsmoking group. None of the CP
and AgP patients and healthy participants had a history or
current manifestation of systemic conditions, which could
modify the periodontal status including the diseases that
have been associated with investigated MMP gene poly-
morphisms (cancer, cardiovascular diseases, or respiratory
diseases) or had transmissible infectious diseases (human
immunodeficiency virus, hepatitis). Pregnancy was also
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Participants eligible for the study signed the informed
consent. The Research Ethics Committee of Kaohsiung
Medical University Hospital (KMUH-IRB970384) and Chung
Shan Medical University Hospital (CSMUH No. CS09107)
approved the study protocol. Periodeontitis patients were
diagnosed in accordance with the clinical criteria for CP or
AgP as established by consensus at the World Workshop in
Periodontics in 1999.28
Genomic DNA preparation and quantitation
A 20-mL sample of whole blood was collected into EDTA-
coated vacutainer tubes using the standard venipuncture
method, then centrifuged at 4C (1600 g) for 10 minutes.
Genomic DNA was extracted from peripheral leukocytes
using standard phenol/chloroform extraction techniques,
and precipitated by ethanol using the DNA isolation kit
(Puregene, Gentra System, Minneapolis, MN, USA) accord-
ing to the procedure described by Blin and Stafford.29 DNA
concentration was determined by spectrophotometry at
280 nm (UV) wavelength and diluted as 10 ng/mL.
Genotyping of MMP-2, MMP-9, and TIMP-2
The SNPs of the genotypes at positions of MMP-2 -1306,
MMP-2 -790, MMP-2 -735, MMP-9 -1562, and TIMP-2 -418
from the transcription start site were detected by poly-
merase chain reaction (PCR) amplification followed by re-
striction enzyme digestion. The synthetic oligonucleotide
primer sequences, PCR conditions for MMP-2, MMP-9, and
TIMP-2 restriction fragment length polymorphisms and PCR
products are outlined in Table 1.
Statistical analysis
PowerMarker version 3.25 (GlaxoSmithKline, NC, USA) was
used to test for deviation of genotype frequencies from
HardyeWeinberg equilibrium. Comparisons of descriptiveTable 1 PCR conditions for MMP-2, MMP-9, and TIMP-2 restricti
Gene Primes
MMP-2 -1306C/T 50-CTTCCTAGGCTGGTCCTTACTGA-30 (forwar
50-CTGAGACCTGAAGAGCTAAAGACCT-30 (reve
(95C, 10 min, 35 cycles then 95C, 45 s then 55C, 45 s; 72C, 45
MMP-2 -790T/G 50-GGGTCTTTTGTGACCTCGATC-30 (forward)
50-GGTAAAATGAGGCTGAGACCTG-30 (reverse
(95C, 10 min, 40 cycles then 95C, 45 s then 55C 45 s, 72C, 45
MMP-735C/T 50-ATAGGGTAAACCTCCCCACATT-30 (forward)
50-GGTAAAATGAGGCTGAGACCTG-30 (reverse
(95C, 10 min, 40 cycles then 95C, 45 s then 55C 45 s, 72C, 45
TIMP-2 -418G/C 50-CGTCTCTTGTTGGCTGGTCA-30 (forward)
50-CCTTCAGCTCGACTCTGGAG-30 (reversed)
(94C, 4 min, 35 cycles then 94C, 1 min, then 56C 45 s, 72C, 4
MMP-9 -1562C/T 50- GGGATAATTTGGCTCTGGTCTTCAA-30 (for
50-CCATGGGAACCATAGAAAAGA-30 (reversed)
94C, 10 min, 35 cycles then 95C, 30 s, 59C, 45 s, 72C, 45 s
MMP Z matrix metalloproteinase; PCR Z polymerase chain reaction;statistics in the three groups are shown as mean ( stan-
dard deviation) and within-group proportions. The c2 test
and analysis of variance test were used to compare the
proportions and means, respectively, and to evaluate the
statistical significance of differences among the three
groups. The risk associated with genotype and periodontitis
was calculated using simple logistic regression and dis-
played as the odds ratio (OR) with 95% confidence interval
(CI). A multivariate logistic regression was used to assess
the relationship of the genotype to disease status while
adjusting for the potential confounding effects of age, sex,
and smoking status, which were used as independent vari-
ables. A P value < 0.05 was considered statistically signif-
icant. All data analyses were performed using the statistical
package SPSS version 17.0 (SPSS Inc., Chicago, IL, USA).
Results
Overall, 87 CP patients, 69 AgP patients, and 117 healthy
controls (HCs) had fulfilled the minimal required sample
size for genotyping test. The demographic parameters of
the study groups are summarized in Table 2. Significant
differences in age, habits of betel quid chewing, smoking,
and alcohol drinking were noted among these three groups.
No significant differences in the genotype distributions of
the MMP-2 C-1306T and C-735T, and MMP-9 C-1562T among
periodontitis and control groups were detected in our study
(Table 3). There was only a trend of difference in the allele
distributions of the MMP-2 T-790G and genotype distribu-
tions of TIMP-2 G-418C (Table 3, P Z 0.08). The MMP-2 T-
790G and TIMP-2 G-418C genotypes in the CP and healthy
groups were found in accordance with those expected by
the HardyeWeinberg equilibrium.
Next, the study participants were subcategorized ac-
cording to their smoking, betel quid chewing, and alcohol
drinking habits. Multiple logistic regression analysis was
used to evaluate the association of the rare allele-carrying
genotypes with periodontal disease susceptibility, while
adjusting for modifying factors such as age, sex, and
smoking. The logistic regression indicated that TIMP-2 G-on fragment length polymorphisms.
Restriction enzyme
d) XspI 188 þ 162 þ 26 bp (CT); 188 bp (CC)
rse) 162 þ 26 bp (TT)
s)
PvuI 118 þ 99 þ 19 bp (TG); 118 bp (TT)
) 99 þ 19 bp (GG)
s)
HinfI 300 þ 254 þ 46 bp (CT); 300 bp (CC)
) 254 þ 46 bp (TT)
s)
BsoBI 230 þ 51 þ23 bp (GG); 230 þ 51 bp (CC)
253 þ 230 þ 51 þ 23 bp (CC)
5 s)
ward) SphI 436 bp (CC);
436 þ 194 þ 242 bp (CT)
TIMP, tissue inhibitor of MMPs.
Table 2 Demographic data of participants in healthy control (HC), aggressive periodontitis (AgP), and chronic periodontitis
(CP) groups.
HC
n Z 117 (%)
AgP
n Z 69 (%)
CP
n Z 129 (%)
c2 P
Age (mean  SD) 45.5  11.3 39.0  10.1 50.8  8.6 31.48 0.000
Sex
Male 57 (48.7) 41 (59.4) 74 (57.4) 2.68 0.260
Female 60 (51.3) 28 (40.6) 55 (42.6)
Habit
BQ chewing
Yes 8 (6.8) 10 (14.5) 28 (21.7) 10.88 0.004
No 109 (93.2) 59 (85.5) 101 (78.3)
Smoking
Yes 20 (17.1) 26 (37.7) 51 (39.5) 16.47 0.000
No 97 (82.9) 43 (62.3) 78 (60.5)
Al drinking
Yes 30 (25.6) 29 (42.0) 65 (50.4) 16.00 0.000
No 87 (74.4) 40 (58.0) 64 (49.6)
Al drinking Z alcohol drinking; BQ chewing Z betel quid chewing; SD Z standard deviation.
Table 3 Association of MMP-2-1306, -790, and -735, MMP-9-1562 and TIMP2 418 genotypes, and allele with healthy control
(HC), aggressive periodontitis (AgP), and chronic periodontitis (CP) groups.
Genotype HC
n Z 117 (%)
AgP
n Z 69 (%)
CP
n Z 129 (%)
c2 P
MMP-2-1306
CC 105 (89.7) 62 (89.9) 114 (88.4) 1.49 0.83
CT 12 (10.3) 7 (10.1) 14 (10.9)
TT 0 (0.0) 0 (0.0) 1 (0.8)
C allele 222 (94.9) 131 (94.9) 242 (93.8) 0.35 0.84
T allele 12 (5.1) 7 (5.1) 16 (6.2)
MMP-2-735
CC 57 (48.7) 39 (56.5) 75 (58.1) 2.98 0.56
CT 48 (41.0) 26 (37.7) 44 (34.1)
TT 12 (10.3) 4 (5.8%) 10 (7.8)
C allele 162 (69.2) 104 (75.4) 194 (75.2) 2.71 0.26
T allele 72 (30.8) 34 (24.6) 64 (24.8)
MMP-2-790
TT 98 (83.8) 52 (75.4) 95 (73.6) 5.80 0.21
GT 18 (15.4) 17 (24.6) 31 (24.0)
GG 1 (0.9) 0 (0.0) 3 (2.3)
T allele 214 (91.5) 121 (87.7) 219 (84.9) 5.00 0.08
G allele 20 (8.5) 17 (12.3) 39 (15.1)
TIMP-2-418
GG 73 (62.4) 48 (69.6) 94 (72.9) 8.51 0.08
GC 44 (37.6) 19 (27.5) 31 (24.0)
CC 0 (0.0) 2 (2.9) 4 (3.1)
G allele 188 (81.7) 114 (83.8) 219 (84.9) 0.89 0.64
C allele 42 (18.3) 22 (16.2) 39 (15.1)
MMP-9-1562
CC 90 (76.9) 48 (69.6) 96 (74.4) 1.48 0.83
CT 28 (21.4) 19 (27.5) 31 (24.0)
TT 2 (1.7) 2 (2.9) 2 (1.6)
C allele 205 (87.6) 115 (83.3) 223 (86.4) 1.35 0.51
T allele 29 (12.4) 23 (16.7) 35 (13.6)
MMP Z matrix metalloproteinase; TIMP, tissue inhibitor of MMPs.
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Table 4 Genotypes and allele distributions in nonsmokers of healthy control (HC), aggressive periodontitis (AgP), and chronic
periodontitis (CP) groups.
Genotype HC
n Z 97 (%)
AgP
n Z 43 (%)
CP
n Z 78 (%)
c2 P
MMP-2-1306
CC 88 (90.7) 40 (93.0) 68 (87.2) 2.535 0.64
CT 9 (9.3) 3 (7.0) 9 (11.5)
TT 0 (0.0) 0 (0.0) 1 (1.3)
C allele 185 (95.4) 83 (96.5) 145 (92.9) 1.691 0.43
T allele 9 (4.6) 3 (3.5) 11 (7.1)
MMP-2-735
CC 45 (46.4) 24 (55.8) 40 (51.3) 2.117 0.71
CT 41 (42.3) 17 (39.5) 31 (39.7)
TT 11 (11.3) 2 (4.7) 7 (9.0)
C allele 131 (67.5) 65 (75.6) 111 (71.2) 1.920 0.38
T allele 63 (32.5) 21 (24.4) 45 (28.8)
MMP-2-790
TT 81 (83.5) 33 (76.7) 58 (74.4) 5.258 0.26
GT 16 (16.5) 10 (23.3) 18 (23.1)
GG 0 (0.0) 0 (0.0) 2 (2.5)
T allele 178 (91.8) 76 (88.4) 134 (85.9) 3.068 0.22
G allele 16 (8.2) 10 (11.6) 22 (14.1)
TIMP-2-418
GG 60 (61.9) 29 (67.4) 61 (78.2) 11.270 0.024
GC 37 (38.1) 13 (30.2) 14 (17.9)
CC 0 (0.0) 1 (2.4) 3 (3.9)
G allele 156 (81.3) 70 (83.3) 136 (87.2) 2.245 0.33
C allele 36 (18.7) 14 (16.7) 20 (12.8)
MMP-9-1562
CC 77 (79.4) 32 (74.4) 57 (73.1) 4.967 0.29
CT 18 (18.6) 9 (20.9) 21 (26.9)
TT 2 (2.0) 2 (4.7) 0 (0.0)
C allele 172 (88.7) 73 (84.9) 135 (86.5) 0.842 0.66
T allele 22 (11.3) 13 (15.1) 21 (13.5)
MMP Z matrix metalloproteinase; TIMP, tissue inhibitor of MMPs.
Gene polymorphisms of MMP-2, -9, and TIMP-2 415418C gene polymorphisms in nonsmokers were statistically
significantly different among AgP, CP, and HC groups
(P Z 0.024, Table 4); the participants with MMP-2 -970 TT
genotypes and T allele as compared to GT þ GG genotypes
and G allele, were less susceptible to CP (adj. OR Z 0.50,
95% CI Z 0.25e1.00 and adj. OR Z 0.52, 95%
CIZ 0.23e0.96, respectively; Table 5), and the nonalcohol
drinking participants with MMP-9-1562 C allele as compared
to those with T allele, were less susceptible to AgP but not
to CP (adj. OR Z 0.4, 95% CI Z 0.18e0.90; Table 6).Discussion
The human MMP-2 gene exhibits sequence variations, and
several functional SNPs in the MMP-2 promoter have been
described.30,31 A C/T polymorphism located at nucleotide
1306 site disrupts an Sp1 regulatory element, and the T
allele thus has a strikingly lower promoter activity
compared with the C allele.20 Recently, a previous study
showed that another C/T polymorphism located at
nucleotide 735 also destroys an Sp1 binding element, with
the T allele being associated with significantly diminishedpromoter activity.31 The 1306C/T and 735C/T poly-
morphisms are in a linkage disequilibrium and the
T1306eT735 haplotype displays an even lower promoter
activity and mRNA expression compared with the haplotype
consisting of only one T allele at the 1306 or 735 site,
indicating an interactive effect of these two SNPs on MMP-2
transcriptional function.31 The study observed an increased
risk of the cancer associated not only with the 1306C
allele but also with the 735C allele; furthermore, an even
greater association was observed between elevated risk of
developing esophageal squamous cell carcinoma (SCC) and
C1306 and C735-allele containing haplotypes.32 A contri-
bution of MMP-2 C1306 and C735-allele containing haplo-
types, alone or in combination with smoking, to the risk of
developing lung cancer in a caseecontrol study has been
reported.33 A joint effect between the MMP-2 promoter
polymorphisms and tobacco smoking was evident. The
1306CC and 735CC genotypes or the C1306eC732
haplotype were significantly associated with lung cancer
risk in nonsmokers; however, the risk was markedly
elevated in smokers, particularly heavy smokers, suggesting
an additive geneesmoking interaction. Tobacco smoking is
an established etiological factor for lung cancer; therefore,
Table 5 Logistic regression analysis of the associations of the genotypes and allele frequencies of MMP-2 -1306, -790, and
-735, MMP-9 -1562, and TIMP-2 -418 genes, and chronic periodontitis (CP) risks.
Genotype HC
n Z 117 (%)
CP






CT/TT 12 (10.3) 15 (11.6) 1 1
CC 105 (89.7) 114 (88.4) 0.87 (0.39e1.94) 0.94 (0.39e2.26)
T allele 12 (5.1) 16 (6.2) 1 1
C allele 222 (94.9) 242 (93.8) 0.82 (0.38e1.77) 0.87 (0.38e2.00)
MMP-2-735
TT 12 (10.3) 10 (7.8) 1 1
CT 48 (41.0) 44 (34.1) 1.1 (0.43e2.80) 1.18 (0.42e0.34)
CC 57 (48.7) 75 (58.1) 1.58 (0.64e3.91) 1.78 (0.64e4.93)
T allele 72 (30.8) 64 (24.8) 1 1
C allele 162 (69.2) 194 (75.2) 1.35 (0.91e2.00) 1.41 (0.91e2.18)
MMP-2-790
GT/GG 19 (16.2) 34 (26.4) 1 1
TT 98 (83.8) 95 (73.6) 0.54 (0.29e1.02) 0.50* (0.25e1.00)
G allele 20 (8.5) 39 (15.1) 1 1
T allele 214 (91.5) 219 (84.9) 0.53* (0.30e0.93) 0.52* (0.28e0.96)
TIMP-2-418
GC/CC 44 (37.6) 35 (27.1) 1 1
GG 73 (62.4) 94 (72.9) 1.62 (0.94e2.78) 1.46 (0.81e2.63)
G allele 188 (81.7) 219 (84.9) 1 1
C allele 42 (18.3) 39 (15.1) 0.8 (0.50e1.29) 0.9 (0.53e1.51)
MMP-9-1562
TT 2 (1.7) 2 (2.9) 1 1
CT 28 (21.4) 19 (27.5) 1.24 (0.16e9.44) 0.94 (0.11e7.91)
CC 90 (76.9) 48 (69.6) 1.07 (0.15e7.73) 0.99 (0.13e7.83)
T allele 29 (12.4) 35 (13.6) 1 1
C allele 205 (87.6) 223 (86.4) 0.9 (0.53e1.53) 1.04 (0.58e1.83)
* P < 0.05.
HC Z healthy control; MMP Z matrix metalloproteinase; OR Z odds ratio; TIMP, tissue inhibitor of MMPs.
a Adjustment for age, sex, and habits of betel quid chewing, alcohol drinking, and smoking.
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higher risk of lung cancer among smokers who carried the
susceptible genotypes or haplotypes may be attributed to
many transformed or preinvasive lung cells caused by to-
bacco carcinogens, which in turn increases the possibility
that one of these cells will become an invasive tumor under
the condition of higher lifetime expression of MMP-2. In
addition, MMP expression can be induced by smoking.32,34
Given these conditions, it would be expected that in-
dividuals who smoked and carried the 1306CC and 735CC
genotypes or the C1306eC732 haplotype were more sus-
ceptible to developing lung cancer. A trend to decreased
frequency of the MMP-2-790 GG homozygotes was observed
in patients with CP compared to HC (P Z 0.036, corrected
P > 0.05).29
TIMP-2 expression was identified in fibroblasts, macro-
phages, and epithelial cells and was significantly increased
in periodontitis-affected gingival tissues when compared to
healthy gingival tissues.35 Gene polymorphisms of MMP-2
did not show any association with the generalized AgP
(GAgP), but the frequencies of TIMP-2-418 G to C gene
polymorphism revealed significant differences between
patients and controls (a significant increasing trend of
TIMP-2 -418C carrier in GAgP patients occurred).1 Consid-
ering the roles of MMP-2 in cell proliferation, apoptosis, andangiogenesis,30 it is no surprise that participants with
functional genotypes in the MMP-2 promoter are genetically
more susceptible to carcinogenesis. Within this context,
our results suggested that TIMP-2 G-418C may be associated
with the risk of different subtypes of periodontitis (AgP vs.
CP).
To date, only a few studies have evaluated the associ-
ation between MMP-9 -1562 C/T polymorphism and perio-
dontitis.36e38 No association was revealed between MMP-9
-1562 T/T genotype and T allele distribution of this gene
and CP in a Brazilian population. The similar frequencies of
MMP-9 -1562T/T genotype and allele frequencies of this
polymorphism were also found in CP patients and healthy
individuals in a Czech population.36 The T allele of the
MMP-9 -1562 gene was significantly higher in severe CP
when compared to the moderate form of CP.36 By contrast,
a significantly different genotype distribution has been
found between CP patients and healthy controls regarding
MMP-9 -1562 C/T polymorphism in a Turkish population.37 T
allele carriage of MMP-9 -1562 gene polymorphisms in
Turkish GAgP patients was found to be lower than that of
healthy individuals and was found to be associated with
decreased susceptibility to GAgP (adjusted OR Z 0.52).26
Although not significant (P Z 0.06), higher T allele car-
riage in the healthy group than in the CP group was
Table 6 Associations of genotypes and allele frequencies of MMP-2 -1306, -790, and -735, MMP-9 -1562 and TIMP-2 -418 genes,
and AgP risks in nonalcohol-drinking participants using logistic regression analysis.
Genotype HC
n Z 87 (%)
AgP






CT/TT 7 (8.0) 3 (7.5) 1.00 1.00
CC 80 (92.0) 37 (92.5) 1.08 (0.26e4.41) 0.88 (0.19e3.98)
T allele 7 (4.1) 3 (3.7) 1.00 1.00
C allele 165 (95.9) 77 (96.3) 1.08 (0.27e4.27) 0.86 (0.20e3.72)
MMP-2-735
TT 9 (10.4) 2 (5.0) 1.00 1.00
CT 31 (35.6) 15 (37.5) 2.18 (0.42e11.36) 1.96 (0.34e11.30)
CC 47 (54.0) 23 (57.5) 2.20 (0.44e11.03) 2.06 (0.38e11.26)
T allele 49 (28.5) 19 (23.7) 1.00 1.00
C allele 123 (71.5) 61 (76.3) 1.26 (0.68e2.32) 1.26 (0.65e2.43)
MMP-2-790
GT/GG 12 (13.8) 9 (22.5) 1.00 1.00
TT 75 (86.2) 31 (77.5) 0.55 (0.21e1.44) 0.63 (0.23e1.75)
G allele 13 (7.6) 9 (11.2) 1.00 1.00
T allele 159 (92.4) 71 (88.8) 0.64 (0.26e1.56) 0.69 (0.27e1.79)
TIMP-2-418
GC/CC 32 (36.8) 11 (27.5) 1.00 1.00
GG 55 (63.2) 29 (72.5) 1.53 (0.68e3.48) 1.73 (0.71e4.22)
G allele 140 (82.4) 68 (85.0) 1.00 1.00
C allele 30 (17.6) 12 (15.0) 0.80 (0.39e1.66) 0.72 (0.33e1.56)
MMP-9-1562
CT/TT 18 (20.7) 14 (35.0) 1.00 1.00
CC 69 (79.3) 26 (65.0) 0.48 (0.21e1.11) 0.40 (0.16e1.02)
T allele 19 (11.0) 16 (20.0) 1.00 1.00
C allele 153 (89.0) 64 (80.0) 0.49 (0.24e1.01) 0.40* (0.18e0.90)
* P < 0.05.
AgP Z aggressive periodontitis group; CI Z confidence interval; HC Z healthy control group; MMP Z matrix metalloproteinase;
OR Z odds ratio; TIMP, tissue inhibitor of MMPs.
a Adjustment for age, sex, and habits of betel-quid chewing and smoking.
Gene polymorphisms of MMP-2, -9, and TIMP-2 417in agreement with these previous Turkish population
studies.26,37 Moreover, logistic regression analysis revealed
an adjusted OR of 0.36, indicating a decreased suscepti-
bility to CP in T allele carriers. Genotype distribution and
rare allele carriage of MMP-9 -1562 C/T gene polymorphism
in a Turkish population seem to be in contrast to the
probable linkage between MMP-9 -1562 T allele carriage and
increased MMP-9 function and consequently to the peri-
odontal destruction. These results are also in contradiction
to the results of previous studies in other populations.36
The higher frequency and carriage of T allele in the
healthy group might be of importance in supporting the
recent findings indicating defensive anti-inflammatory
properties of MMP-9.36e40 In addition, it should be kept in
mind that MMP-9 activity is also modulated by activation of
the proenzyme and by regulation of MMP inhibitors.
In conclusion, a significant difference (PZ 0.024) in the
frequencies of TIMP-2 G-418C polymorphisms among non-
smokers in the AgP, CP, and HC groups were observed.
However, the logistic regression analysis revealed that
MMP-2 -790TT genotype and T allele might be a protective
factor for CP. The MMP-9-1562 C allele was found to be a
significant protective factor for AgP after adjustment for
age, sex, betel quid chewing, and smoking in nonalcohol
drinking individuals. Additional multicenter studies arenecessary to clarify whether genetic variations within the
MMP genes contribute to interindividual differences in
susceptibility to severe CP and AgP.
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